Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular for obesity treatment. Other companies like Allina Health and PwC have also adjusted their coverage policies. However, Bank of America views GLP-1 coverage as a vital employee health investment.
Jannik Sinner has withdrawn from the Cincinnati Open due to a right knee injury. This…
A consumer commission ordered Kapoor Jewellers to return 32 grams of gold. The jewellers failed…
VVS Laxman has revealed why he turned down the India head coach role after Rahul…
Post Content